Watch Ticker

Applied Therapeutics, Inc. Common Stock

Go to Applied Therapeutics, Inc. Common Stock Website

$0.46

-0.01 (-2.06%)

Live

Previous Close

$0.47

Day Range

$0.4618 - $0.4833

Previous Day Range

$0.431201 - $0.47

Market Cap

$62.4 million USD

Day Vol.

653489

Previous Day Vol.

551840

Currency

USD

Primary Exchange

Nasdaq

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting

Applied Therapeutics presented positive 12-month and 24-month data from its INSPIRE trial of govorestat for the treatment of Charcot-Marie-Tooth Sorbitol Dehydrogenase Deficiency (CMT-SORD), a rare neuromuscular disease. The data showed significant reductions in blood sorbitol levels and improvements in functional and patient-reported outcomes.

Related tickers: APLT.

Read Full Article

N/A - Applied Therapeutics Reports First Quarter 2025 Financial Results

Applied Therapeutics, a clinical-stage biopharmaceutical company, will present full 12-month clinical data and new topline 18-month and 24-month data from its INSPIRE Phase 3 trial of govorestat in CMT-SORD Deficiency at the Peripheral Nerve Society 2025 Annual Meeting. The company is also reviewing the development programs for govorestat in Classic Galactosemia and CMT-SORD Deficiency.

Related tickers: APLT.

Read Full Article

Trending Tickers

Please sign in to view